Press-release for stocks

Prices are updated after-hours

approved crawled time : 12:00

save search

Aemetis to Present to Institutional Investors at UBS, JP Morgan and Stifel Conferences to Review Recent Federal Approval of $200 Million of EB-5 Funding for SAF, Biogas, and CCS Projects
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
AMTX | $3.89 7.31% 6.81% 1.2M

Process Industries

| 1.56% | O: -1.3% H: 2.9% C: 2.9%
approval review million for funding

BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
Published: 2024-04-23 (Crawled : 12:00) - biospace.com/
BGNE | $139.22 6.32% 5.95% 200K

Health Technology

| 5.97% | O: 3.5% H: 4.77% C: 2.39%
lung approval cancer cell treatment for

ContextLogic Announces Stockholder Approval of Transaction with Qoo10
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
WISH | $5.99 2.22% 2.17% 690K

| 22.37% | O: 16.65% H: 5.08% C: 2.28%
approval

Blue World Acquisition Corporation Postponed the Extraordinary General Meeting to Approve the Business Combination with TOYO Solar Pending A Post-Effective Amendment to The Registration Statement
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
BWAQ | $11.25 -0.08% 4

n/a

| -0.08% | O: -0.08% H: 0.0% C: 0.0%
business world corporation solar acquisition meeting blue

FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K

Health Technology

| 2.97% | O: 1.47% H: 1.16% C: -1.27%
AZN | News | $70.85 1.03% 1.02% 5.6M

Health Technology

| 4.78% | O: 3.34% H: 0.27% C: -0.62%
children approved treatment for

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
VVOS | $2.64 -1.12% 35K

Health Technology

| -12.54% | O: -0.33% H: 13.91% C: -8.77%
approval care for medical

Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
VERO | $0.787 -6.79% -7.28% 19K

Health Technology

| 4.25% | O: 1.51% H: 0.0% C: -9.59%
approval for max

C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
CCCC | $6.89 0.44% 0.44% 910K

Health Technology

| -9.92% | O: -1.57% H: 0.0% C: 0.0%
cft1946 association approved cancer care research preclinical for meeting therapeutics

Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
Published: 2024-04-03 (Crawled : 12:00) - globenewswire.com
VERO | $0.787 -6.79% -7.28% 19K

Health Technology

| 20.63% | O: -1.59% H: 18.23% C: 17.74%
pro approval

Hughes Enables Worldwide LEO Connectivity with Eutelsat OneWeb Approval of New ESA
Published: 2024-04-02 (Crawled : 12:00) - prnewswire.com
SATS | $15.295 1.56% 1.54% 1.5M

Electronic Technology

| 7.82% | O: -3.17% H: 0.66% C: -5.09%
leo approval worldwide

Daqo New Energy's Subsidiary Xinjiang Daqo Proposes 2023 Cash Dividend for Approval at Its Annual Shareholders' Meeting
Published: 2024-04-01 (Crawled : 12:00) - prnewswire.com
DQ | $23.01 3.23% 0.0% 530K

Process Industries

| -15.71% | O: 4.69% H: 0.42% C: -1.89%
approval meeting

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
AEZS | $1.97 0.73% 6K

Health Technology

| -0.48% | O: -2.88% H: 6.93% C: 5.94%
approval

Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer
Published: 2024-03-26 (Crawled : 12:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K

Manufacturing

| -12.94% | O: -1.65% H: 3.36% C: 3.17%
japan approved cancer treatment

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE™ Platform for the Treatment of Paroxysmal Atrial Fibrillation
Published: 2024-03-25 (Crawled : 12:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -3.79% | O: 0.04% H: 0.0% C: 0.0%
fda approval treatment application platform

Aemetis Approved by USCIS for $200 million of EB-5 Investment in Biogas, SAF and Carbon Sequestration Projects
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
AMTX | $3.89 7.31% 6.81% 1.2M

Process Industries

| 6.85% | O: 18.36% H: 21.06% C: 18.06%
approved million

Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
CMND | $1.19 -1.28% 30K

n/a

| -6.92% | O: 1.54% H: 1.52% C: -2.27%
patent granted approval treatment china

ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator™ VAR 200 in Patients with Diabetic Kidney Disease
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
ZVSA | $0.5605 -2.49% -2.55% 150K

| -28.25% | O: 7.64% H: 21.41% C: 1.07%
disease kidney cholesterol approval trial therapeutics diabetic

Cardinal Health announces approved science-based climate targets; expands focus across the supply chain
Published: 2024-03-15 (Crawled : 12:00) - prnewswire.com
CAH | $103.37 0.53% 0.0% 2.5M

Distribution Services

| -6.8% | O: -0.96% H: 1.59% C: 1.59%
health approved

Prairie Operating Co. Announces Unanimous Approval of Genesis Oil and Gas Development Plan Adding Multi-Year Inventory of Development Drilling Locations
Published: 2024-03-14 (Crawled : 12:00) - globenewswire.com
PROP | $11.715 -17.15% -20.7% 310K

n/a

| 21.86% | O: 0.82% H: 7.26% C: 2.76%
multi-year approval gas oil

Media Alert: IBM Applauds EU Parliament's Approval of the EU AI Act
Published: 2024-03-13 (Crawled : 12:00) - prnewswire.com
IBM | $182.19 0.16% 0.63% 5.9M

Technology Services